About this item:

517 Views | 259 Downloads

Author Notes:

Correspondence: John C. Lucchesi; Tel: +1 404 727 4943, Fax: +1 404 727 2880, Email: jclucch@emory.edu

Authors' Contributions: SK planned and executed the expression of the protein; ED, DD and NS carried out the MS-MS analysis; JCL supervised the research and writing of the manuscript.

Acknowledgments: We are grateful to Dr. Jason W. Chin for the pBK-AckRS-3 and pCDF PylT-1 plasmids.

Disclosures: The authors declare no conflicts of interest.

Subjects:

Research Funding:

This study was supported by grant GM015691 from the National Institutes of Health to JCL

Keywords:

  • Gene expression
  • Histone
  • Nucleosome
  • Technology

Expression, purification and proteomic analysis of recombinant histone H4 acetylated at lysine 16

Tools:

Journal Title:

Proteomics

Volume:

Volume 13, Number 0

Publisher:

, Pages 1687-1691

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Many histone co-valent modifications have been identified and shown to play key regulatory roles in eukaryotic transcription, DNA damage repair and replication. In vitro experiments designed to understand the mechanistic role of individual modifications require the availability of substantial quantities of pure histones, homogeneously modified at specific residues. We have applied the amber stop codon/suppressor tRNA strategy to the production of histone H4 acetylated at lysine 16, a particularly important isoform of this histone. Our success relies on adapting the H4 DNA sequence to the codon preference of E. coli and on preventing the premature decay of the H4 mRNA. These modifications to the original procedure render it easily applicable to the generation of any co-valently modified histone H4 isoform.

Copyright information:

© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

Export to EndNote